Epidemiological studies provide compelling evidence that glucose-6-phosphate dehydrogenase (G6PD) deficiency individuals are relatively protected against Plasmodium parasite infection. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.